Literature DB >> 26993692

Efficacy of endovenous ablation of the saphenous veins for prevention and healing of venous ulcers.

William A Marston1.   

Abstract

In many countries, endovenous ablation (EVA) has replaced surgical stripping as the preferred method of eliminating saphenous reflux in symptomatic patients. Studies have examined the success of EVA at saphenous closure and improving leg pain and edema. However, less information is available on the ability of these techniques to promote venous leg ulcer healing or to prevent recurrence. The comparison of surgery and compression with compression alone in chronic venous ulceration (ESCHAR) trial identified the role of saphenous stripping in reducing the rate of ulcer recurrence after healing, supporting this procedure for Clinical, Etiologic, Anatomic, and Pathologic (CEAP) clinical class 5 and 6 patients. In patients with venous ulcers, it remains controversial whether EVA procedures provide results similar to those of saphenous stripping in clinically relevant outcomes. This review examines the evidence supporting the use of thermal or nonthermal EVA in patients with healed or active venous ulcers and saphenous insufficiency.
Copyright © 2015 Society for Vascular Surgery. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2014        PMID: 26993692     DOI: 10.1016/j.jvsv.2014.09.009

Source DB:  PubMed          Journal:  J Vasc Surg Venous Lymphat Disord


  2 in total

1.  Study on the efficacy of surgery of the superficial venous system and of compression therapy at early stages of chronic venous disease for the prevention of chronic venous ulceration.

Authors:  Raffaele Serra; Bruno Amato; Lucia Butrico; Andrea Barbetta; Giovanni De Caridi; Mafalda Massara; Francesco G Caliò; Chiara Longo; Gianfranco Dardano; Marco Cannistrà; Gianluca Buffone; Stefano de Franciscis
Journal:  Int Wound J       Date:  2016-05-15       Impact factor: 3.315

2.  A retrospective cohort study comparing two treatments for active venous leg ulcers.

Authors:  Xiaochun Liu; Guofu Zheng; Bo Ye; Weiqing Chen; Hailiang Xie; Teng Zhang; Jing Lin
Journal:  Medicine (Baltimore)       Date:  2020-02       Impact factor: 1.817

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.